Masimo Corporation
NASDAQ:MASIMedical - Devices
+$0.00 today
- Market cap
- $9.42B
- Beta
- 1.10
- P/E (TTM)
- 123.1
- EPS (TTM)
- $1.46
Volume 0.00M
Average 1.08M
MASI Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Masimo CorporationNASDAQ: MASI
Weighted Avg Shares · Q1 FY2026 · quarter ended Apr 2026
Weighted avg shares declines year over year
Q1 FY2026 weighted avg shares of 52.2M shares fell 3.3% year over year, behind the -0.1% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 2.6% from the prior quarter. Over 3 fiscal years it compounded at +0.0% a year.
Context
- Weighted avg shares increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -3.3% toward the trailing-twelve-month pace of -0.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2025
- 53.6M USD
- Year-over-year change
- +0.6%
- 4-year CAGR
- -0.7%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 53.6M | +0.6% |
| FY2024 | 2024-12-28 | 53.3M | +0.9% |
| FY2023 | 2023-12-31 | 52.8M | -1.5% |
| FY2022 | 2022-12-31 | 53.6M | -2.8% |
| FY2021 | 2021-12-31 | 55.17M | — |
Weighted Avg Shares vs competitors
How MASI compares with its peers on the latest reported figures
- MASI's LTM Apr 2026 weighted avg shares of 53.45M shares is the 9th highest of the 11 companies compared; the peer median is 68.82M shares.
- Its year-over-year change of -0.1% is the 6th highest of 11, against a peer median of -0.2%.
- Over three fiscal years its annual growth of +0.0% compares with a peer median of +0.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | 678.48M | -0.4% | +1.4% | |
| LTM Jun 2026 | 515M | +0.7% | +0.6% | |
| LTM Jun 2026 | 273M | +0.0% | +1.0% | |
| LTM Jun 2026 | 116.5M | -6.1% | -3.9% | |
| FY2025 | 69.53M | +10.3% | +53.9% | |
| LTM Sep 2026 | 68.12M | +7.8% | +7.6% | |
| LTM Jun 2026 | 64.65M | -2.5% | +0.2% | |
| LTM Jun 2026 | 56.37M | +0.5% | +0.5% | |
| LTM Apr 2026 | 53.45M | -0.1% | +0.0% | |
| LTM Sep 2026 | 51.15M | -7.0% | -4.2% | |
| LTM Jun 2026 | 26.9M | -3.2% | -2.9% | |
| Peer median (excluding MASI) | 68.82M | -0.2% | +0.5% | |
Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.24B | 2.04B | 2.05B | 2.09B | 1.53B |
| Cost of Revenue | 430.8M | 977M | 1.04B | 1.09B | 581.7M |
| Gross Profit | 808.4M | 1.06B | 1B | 1B | 945.2M |
| Gross Margin | 65.2% | 52.0% | 49.0% | 48.0% | 61.9% |
| Research & Development | 137.2M | 191.4M | 175.2M | 222.8M | 126.4M |
| Selling, General & Admin | 395.4M | 657.4M | 664M | 743.8M | 506M |
| Operating Expenses | 532.6M | 848.8M | 867M | 1.27B | 632.4M |
| Depreciation & Amortization | 35.6M | 136.1M | 98.3M | 103M | 38.8M |
| EBITDA | 310.3M | 355.2M | 236.7M | (158.7M) | 344.6M |
| EBITDA Margin | 25.0% | 17.4% | 11.6% | -7.6% | 22.6% |
| Operating Income | 275.8M | 210M | 136.5M | (266.7M) | 312.8M |
| Operating Margin | 22.3% | 10.3% | 6.7% | -12.7% | 20.5% |
| Interest Income | 900K | 1.8M | 3M | 4.8M | 3.4M |
| Interest Expense | 300K | 25.7M | 50.3M | 43.6M | 33.2M |
| Other Income / Expenses | (1.4M) | (16.6M) | (48.4M) | (38.6M) | (40.2M) |
| Income Before Tax | 274.4M | 193.4M | 88.1M | (305.3M) | 272.6M |
| Pre-Tax Margin | 22.1% | 9.5% | 4.3% | -14.6% | 17.9% |
| Income Tax Expense | 44.8M | 49.9M | 6.6M | (400K) | 64.9M |
| Net Income | 229.6M | 143.5M | 81.5M | (304.9M) | (151.5M) |
| Net Margin | 18.5% | 7.0% | 4.0% | -14.6% | -9.9% |
| EPS (Basic) | 4.16 | 2.68 | 1.54 | (5.72) | (2.83) |
| EPS (Diluted) | 3.98 | 2.60 | 1.51 | (5.72) | (2.80) |
| Weighted Avg Shares | 55.17M | 53.6M | 52.8M | 53.3M | 53.6M |
| Weighted Avg Shares (Diluted) | 57.68M | 55.2M | 54.1M | 53.3M | 54.2M |
Masimo Corporation
NASDAQ:MASI
Intrinsic Alpha fair value
Locked
Current Price
$179.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.